Search Results - "Kanal, E."

Refine Results
  1. 1
  2. 2

    Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence by Kanal, E, Maravilla, K, Rowley, H A

    Published in American journal of neuroradiology : AJNR (01-12-2014)
    “…The aim of this article was to review the properties of the various gadolinium-based contrast agents used for CNS imaging along with the clinical evidence and…”
    Get full text
    Journal Article
  3. 3

    TH‐D‐217A‐01: MR Safety Update, 2012: Where Are We, and Where Are We Going? by Kanal, E

    Published in Medical Physics (01-06-2012)
    “…It has now been almost 3 decades since the introduction of MRI as a vital component of our clinical diagnostic armamentarium. During that time, we have learned…”
    Get full text
    Conference Proceeding Journal Article
  4. 4

    Nephrogenic Systemic Fibrosis Risk Assessment and Skin Biopsy Quantification in Patients with Renal Disease following Gadobenate Contrast Administration by Kanal, E, Patton, T J, Krefting, I, Wang, C

    Published in American journal of neuroradiology : AJNR (01-03-2020)
    “…Nephrogenic systemic fibrosis following administration of intravenous gadobenate during MR imaging is rare. This study aimed to analyze any nephrogenic…”
    Get full text
    Journal Article
  5. 5

    WE‐C(SAM)‐211‐02: Magnetic Resonance Safety Guidelines: Update, 2011 by Kanal, E

    Published in Medical Physics (01-06-2011)
    “…Adverse events involving magnetic resonance safety breaches have helped to bring the topic of MR safety into sharp focus in the professional as well as lay…”
    Get full text
    Conference Proceeding Journal Article
  6. 6
  7. 7
  8. 8

    Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases by TSUSHIMA, Y, KANAL, E, THOMSEN, H. S

    Published in British journal of radiology (01-07-2010)
    “…The aim of this article is to review the published cases of nephrogenic systemic fibrosis (NSF) in Japan. The Japanese medical literature database and MedLine…”
    Get full text
    Journal Article
  9. 9
  10. 10

    T1-weighted parenchyma attenuated inversion recovery: A novel sequence that improves contrast ratio of enhancing brain lesions by Batouli, A., Kanal, E., Gholamrezanezhad, A., Spearman, M.

    Published in Diagnostic and interventional imaging (01-01-2018)
    “…The purpose of this study was to develop and test a parenchyma attenuated T1-weighted inversion recovery MR sequence (PAIR) that increases the contrast between…”
    Get full text
    Journal Article
  11. 11

    A Serial Dilution Study of Gadolinium-Based MR Imaging Contrast Agents by Bleicher, A.G, Kanal, E

    Published in American journal of neuroradiology : AJNR (01-04-2008)
    “…With the approval of gadobenate dimeglumine, higher relaxivity MR contrast agents were introduced into the clinical environment, and multiple in vivo studies…”
    Get full text
    Journal Article
  12. 12

    Gadolinium‐induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury by Kalb, R.E., Helm, T.N., Sperry, H., Thakral, C., Abraham, J.L., Kanal, E.

    Published in British journal of dermatology (1951) (01-03-2008)
    “…Summary Nephrogenic systemic fibrosis (NSF) describes a characteristic fibrosing disorder which typically presents with indurated plaques on the trunk and…”
    Get full text
    Journal Article
  13. 13

    Application of a Semiautomated Contour Segmentation Tool to Identify the Intervertebral Nucleus Pulposus in MR Images by BECHARA, B. P, LECKIE, S. K, BOWMAN, B. W, DAVIES, C. E, WOODS, B. I, KANAL, E, SOWA, G. A, KANG, J. D

    Published in American journal of neuroradiology : AJNR (01-10-2010)
    “…Accurate identification of the NP in MR images is crucial to properly and objectively assess the intervertebral disk. Therefore, computerized segmentation of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Safety considerations in MR imaging by Kanal, E, Shellock, F G, Talagala, L

    Published in Radiology (01-09-1990)
    “…The authors identify eight areas of potential safety concern during clinical magnetic resonance (MR) imaging. These include (a) biologic effects of the static…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates by WOLFE, D, NIRANJAN, A, MURPHEY-CORB, M, GLORIOSO, J. C, TRICHEL, A, WILEY, C, OZUER, A, KANAL, E, KONDZIOLKA, D, KRISKY, D, GOSS, J, DELUCA, N

    Published in Gene therapy (01-12-2004)
    “…Malignant glioma is a fatal human cancer in which surgery, chemo- and radiation therapies are ineffective. Therapeutic gene transfer used in combination with…”
    Get full text
    Journal Article
  18. 18

    MR procedures and biomedical implants, materials, and devices: 1993 update by Shellock, F G, Morisoli, S, Kanal, E

    Published in Radiology (01-11-1993)
    “…To provide information on ferromagnetic metallic implants, materials, and devices that may be exposed to static magnetic fields during magnetic resonance (MR)…”
    Get more information
    Journal Article
  19. 19

    Granulomatous amebic encephalitis in a multivisceral transplant recipient by Mendez, O., Kanal, E., Abu-Elmagd, K. M., McFadden, K., Thomas, S., Bond, G., Živković, S. A.

    Published in European journal of neurology (01-03-2006)
    “…A 40‐year‐old man with multivisceral allograft developed acutely right‐sided numbness 9 months after transplantation. Cranial magnetic resonance imaging (MRI)…”
    Get full text
    Journal Article
  20. 20

    Pregnancy and the safety of magnetic resonance imaging by Kanal, E

    “…Many data exist regarding the safety of the static and time-varying magnetic and electromagnetic fields used in MR environments for the developing fetus. Many…”
    Get more information
    Journal Article